New therapies show promise in treating diabetesNew updates in insulin products, as well as non-pharma therapies are on the horizon for diabetes. Analyst: CVS’ OptumRx deal amps up competition December 06, 2016By Christine BlankLast month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients. Copay assistance programs: Managed care pros and consDo copay assistance program offer a long-term solution for patients? Experts weigh in. Walgreens-Prime alliance: A new breed pharmacy strategy? September 02, 2016By Tracey WalkerThis model, touted as “next-generation,” combines retail and specialty and mail services and PBM along with immediate care clinics. My biggest career mistake: 5 healthcare executives weigh in August 31, 2016By Tracey WalkerLearning how to appreciate the value of experiences is key for these execs, who share their biggest career mistake was and how they learned from it. Walgreens, OptumRx form pharmacy partnership March 22, 2016By Christine BlankThe new partnership between Walgreens Boots Alliance and OptumRx may signal that Walgreens is not looking to buy another PBM. Six ways to combat pharma price gougingDrug price increases can prove challenging for payers. Here’s six strategies to keep in your arsenal. New psoriasis therapies must demonstrate value December 01, 2015By Tracey WalkerPsoriasis affects a small percentage of the population but price increases for drug treatments have outpaced the Consumer Price Index. Watch list 2016: Top therapeutic areas
November 30, 2015Experts say you should follow these 6 therapeutic areas.